Logo 11 Sep 2025

Quick take | Washington’s fear of Chinese biotech could be just what Beijing needs

Subscribe to keep reading.

Trivium Tech keeps you briefed on the latest developments in China tech policy.

Try it free

Already a subscriber? Log in.

The Trump administration is considering an executive order (E.O.) that would block US pharma companies from buying Chinese-developed drug candidates. 
Per the New York Times:

“At the heart of the possible clampdown is a drafted executive order that threatens to cut off the pipeline of Chinese-inven...



More recent developments

Logo October 29, 2025
Quick take | Is China angling to become the world’s lab partner?

Premier Li Qiang wants East Asian countries to participate in more research collaborations. That was the spirit of the speech he delivered on October 27 at the 28th ASEAN Plus China, Japan, and South Korea Summit. What caught our eye:… Read More »

Logo August 28, 2025
Deep dive | The AI Plus plan – China’s blueprint for AI diffusion

On August 26, the State Council published a high-level directive on implementing the AI Plus policy initiative.  This document is a big deal: It represents China's most detailed plan to date addressing how the country intends to develop and diffuse… Read More »

Logo August 14, 2025
Quick take | DeepSeek struggles to train models on Huawei

What happened: On August 14, the FT reported that the launch of DeepSeek's R2 model has been delayed due to difficulties getting Huawei’s Ascend AI chips working for model training. The company has switched back to Nvidia for training, but… Read More »